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Summary 
The occurrence of variant Creutzfeldt-Jacob disease (vCJD) in humans was 
almost certainly the result of consumption of food contaminated with bovine 
spongiform encephalopathy (BSE) prions.  Despite probable widespread 
exposure of the UK population to BSE-contaminated food in the 1980s, vCJD 30 
has predominantly been identified in young individuals, and there have been 
fewer cases of clinical disease than anticipated.  The reasons for this are 
uncertain.  Following peripheral exposure many prions replicate within the 
lymphoid tissues before infecting the CNS.  We have shown that the effects of 
host age on the microarchitecture of the spleen significantly impair susceptibility 
to mouse-adapted prions after peripheral exposure.  The transmission of prions 
between different mammalian species is considered to be limited by the “species 
barrier,” which is dependent on several factors including an intact immune 
system.  Thus, cross-species prion transmission may be much less efficient in 
aged individuals.  To test this hypothesis, we compared prion pathogenesis in 40 
groups of young (six to eight weeks old) and aged (600 d old) mice injected with 
primary BSE.  We show that prion pathogenesis was dramatically impaired in 
aged mice when compared to young animals.  Whereas most young mice 
succumbed to clinical prion disease, all aged mice failed to develop clinical 
disease during their lifespans.  However, the demonstration that prion 
accumulation was detected in the lymphoid tissues of some aged mice after 
injection with primary BSE, in the absence of clinical signs of prion disease, has 
important implications for human health. 
 
 50 
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INTRODUCTION 
Transmissible spongiform encephalopathies (TSEs) or prion diseases are sub-
acute neurodegenerative diseases which affect humans and animals.  These 
diseases are defined by a number of characteristic pathological changes in the 
central nervous system (CNS) including vacuolation of the neuropil, gliosis and 
aggregations of PrPSc an abnormally folded isoform of the cellular prion protein 
(PrPc).  The precise nature of the infectious prion is uncertain, but PrPSc is 
considered to constitute the major, if not sole, component (Bolton et al., 1982, 
Legname et al., 2004). 
 60 
In 1996 a “new variant” of CJD (vCJD) was described in 10 individuals with a 
clinical and pathological phenotype distinct from that of sporadic (s)CJD (Will et 
al., 1996).  Transmissions to mice have produced compelling evidence to show 
that brain material from vCJD affected individuals produces a signature 
undistinguishable from that of BSE (Bruce et al., 1997).  The components of this 
signature include; distinct incubation periods in specific mouse strains; distinct 
neuropathological characteristics in the brains of recipient mice; and distinct 
PrPSc glycoforms (Somerville et al., 2005).  One of the most striking features of 
vCJD is the young age of the affected individuals (median age at onset of 
disease ~26 years old) (Boelle et al., 2004, Ghani et al., 2000) (Fig. S1).  Of the 70 
177 recorded definite and probably vCJD cases which had been reported in the 
UK at the time of writing (August 2013), the majority had occurred in young 
patients, with only 5 cases (2.8%) observed in the eldery (≥60 years old).  This 
contrasts starkly with those affected with sCJD which typically affects individuals 
>60 years old.  The reasons behind this apparent age-related susceptibility are 
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not fully understood.  A causal link between dietary preference (the consumption 
of foodstuffs considered to be at high risk of BSE contamination) and disease 
incidence in the young has not been substantiated (Boelle et al., 2004), 
suggesting that other factors may significantly influence susceptibility.  
 80 
Although the major pathology associated with prion infection appears to be 
restricted to the CNS, the peripheral immune system plays an essential role in 
the pathogenesis of many natural and experimental prion diseases (Mabbott, 
2012).  Studies with mouse-passaged prions show that following peripheral 
exposure, early prion accumulation and replication occurs upon follicular 
dendritic cells (FDC) within the secondary lymphoid tissues prior to the spread of 
infection to the CNS (termed neuroinvasion) (Brown et al., 1999, McCulloch et 
al., 2011). Prion replication upon FDC is a critical stage in the neuroinvasion 
process as disease susceptibility is impaired in their absence (Mabbott et al., 
2000, Mabbott et al., 2003, Montrasio et al., 2000).  While prion replication in 90 
Peyer’s patches of the intestine and spleen appears to be dependent upon PrPC-
expressing FDC, data from an elegant study has revealed that some prion strains 
can also accumulate in association with high endothelial venules in lymph nodes 
(O'Connor et al., 2012).  Following peripheral exposure to many natural prion 
diseases, including natural scrapie in sheep (Andreoletti et al., 2000), chronic 
wasting disease (CWD) in cervids (Sigurdson et al., 1999), and vCJD in humans 
(Hilton et al., 1998), early agent accumulation also appears to occur first upon 
FDC within the secondary lymphoid tissues prior to the spread of infection to the 
CNS.  In mammals host age has a significant influence on immune function.  In 
the spleens of aged mice (≥600 d old) FDC status is adversely affected and the 100 
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marginal zone (MZ) is disrupted (Aydar et al., 2002, Aydar et al., 2003, Birjandi et 
al., 2011, Brown et al., 2012, Brown et al., 2009).  Our data show that the effects 
of aging on the splenic microarchitecture impede the delivery of prion-containing 
immune complexes from the MZ to FDC, and as a consequence, reduce disease 
susceptibility to mouse adapted prions (Brown et al., 2012, Brown et al., 2009).   
 
The transmission of prions strains within the same host species usually occurs 
efficiently and with highly reproducible disease characteristics (similar incubation 
periods, neuropathology etc.). However, prion transmission between different 
species on the first passage are typically characterised by low efficacy and 110 
prolonged disease incubation periods: termed the “species barrier” effect.  
Several factors are known to have an important influence on the species barrier.  
Data suggest that the species barrier is due to incompatibility between the PrP of 
the infectious prion and the recipient (host) species, with differences in the PrP 
species or polymorphisms and mutations in the PRNP genotype (which encodes 
PrPC) having significant influence (Barron et al., 2001, Bishop et al., 2006, 
Houston et al., 2003, Prusiner et al., 1990).   However, the precise molecular 
mechanism responsible for these effects is uncertain.  Studies using 
immunodeficient mice have shown that a functional immune system is also 
essential for the efficient cross-species transmission of BSE prions (Brown et al., 120 
1997).  Severely combined immunodeficient mice (SCID) mice which lack 
functional, mature FDC in their lymphoid tissues show dramatically reduced 
susceptibility to prion infection following injection with primary BSE prions.  This 
suggests that the effects of aging on FDC status and the splenic MZ may 
likewise impede the cross-species transmission of BSE.  To test this hypothesis, 
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we compared primary prion pathogenesis in young and aged mice injected with 
primary BSE.  Our data show that aged mice did not develop clinical disease 
after BSE exposure.  However, some mice had evidence of prion accumulation in 
their spleens.  These data suggest that while aged individuals may be less 
susceptible to clinical prion disease after BSE exposure, they may accumulate 130 
significant levels of prions within their lymphoid tissues and pose a potential risk 
for the horizontal spread of disease.  
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RESULTS 
Effect of host age on susceptibility to BSE infection  
The transmission of BSE to specific inbred strains of mice produces distinctive 
neuropathological characteristics and reproducible incubation periods (Bruce et 
al., 1997).  Here, following primary BSE injection into groups of young (six – 
eight wk old) RIII mice and young C57BL mice clinical disease was confirmed in 
the majority of the recipients with incubation periods consistent with previously 140 
published data (RIII, 361 ± 8 d; C57BL, 505 ± 27 d; Table 1) (Bruce et al., 1997).  
Histopathological analysis of the brains from the clinically-affected young mice 
revealed that the severity and distribution of the vacuolar (spongiform) pathology 
was typical of that associated with BSE transmission to mice (Fig. 1a & 1b) 
(Bruce et al., 1997).  The absence of disease in a small number of the young 
mice (Table 1) was not unexpected since cross species transmission is often 
less efficient.  Of the 17 aged RIII mice that were injected with BSE prions (aged 
RIII mice were 600 d old at the time of BSE injection), 7 survived until after the 
first clinically-positive case in the corresponding young mice (aged RIII mice 
were 928-1041 d old at time of cull; Table 1).  However, there was no evidence 150 
of clinical disease or positive vacuolar pathology in any of the brains from the 
BSE-injected aged RIII mice (Fig. 1a & 1c; Table 1).  Unfortunately, the disease 
incubation period after primary BSE injection in C57BL mice (~500 d) exceeded 
the lifespan of the aged mice in this study (aged C57BL mice were 600 d old at 
time of BSE injection and survived to ~900 d old).  However, histopathological 
analysis of all the brains from the BSE-injected aged C57BL mice, including 9 
animals that survived to over two thirds of the incubation period in the 
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corresponding young mice, found no evidence of vacuolar pathology (Fig. 1b & 
1d; Table 1).   
 160 
Effect of host age on PrPSc accumulation in the brain 
In addition to vacuolar changes, CNS prion infection is accompanied with 
astrogliosis, increased microglial activity and abnormal accumulations of 
disease-specific PrP.  As anticipated, all the brains from the BSE-injected, 
clinically-affected young RIII mice and young C57BL mice with positive vacuolar 
pathology in their brains demonstrated high levels of astrogliosis and microgliosis 
consistent with the terminal stage of prion disease (Fig. 2).  However, none of 
the histopathological characteristics of CNS prion disease were detected in any 
of the brains from the BSE-injected aged RIII mice and C57BL mice (Fig. 2).  
Together, these data show that BSE disease-susceptibility is dramatically 170 
reduced in aged mice.   
In this study, two distinct terms (PrPSc and PrPd) describe the disease-
specific, abnormal accumulations of PrP that are characteristically found only in 
prion-affected tissues.  Prion disease-specific PrP accumulations are relatively 
resistant to proteinase K (PK) digestion, whereas cellular PrPC is destroyed.  
Thus prion-specific PK-resistant PrP (referred to as PrPSc) can often be used as 
a biochemical marker for the presence of prions (Bolton et al., 1982).  On 
histological sections where PK-treatment is not used since it destroys the tissue 
microarchitecture, we refer to these abnormal disease-specific PrP 
accumulations as PrPd.  However, to confirm the presence of prion-specific PK-180 
resistant PrPSc, adjacent brain sections were applied to nitrocellulose membrane, 
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PK-treated and analysed by paraffin-embedded tissue (PET) immunoblot 
(Schulz-Schaeffer et al., 2000).   
Our previous studies of the transmission of mouse-passaged prions to 
aged mice revealed the presence of prion-specific PrPSc deposition in the 
majority of the brains from aged mice after peripheral (intraperitoneal and oral) 
exposure, despite the absence of clinical signs of disease or vacuolar pathology 
(Brown et al., 2009).  We therefore determined whether PrPSc was present in the 
brains of the clinically-negative, BSE-injected aged mice.  Large accumulations 
of PrPd were detected by immunohistochemistry (IHC) in the brains of all the 190 
clinically affected, BSE-infected, young mice (Fig. 2; Table 1).  PET immunoblot 
analysis of adjacent sections confirmed that the PrPd detected by IHC was PK-
resistant, prion-specific PrPSc (Fig. 2).  In contrast, PrPSc was only detected in a 
small foci in the brain of one of the BSE-injected aged RIII mice (the vestibular 
nucleus), and was undetectable in the all the brains from the aged C57BL mice 
(Fig. 2 & 3a; Table 1). 
 
Effect of host age on the accumulation of PrPd in spleen 
The accumulation of high levels of PrPSc upon FDC in lymphoid tissues is a 
characteristic feature of many experimental and natural prion infections, and 200 
studies in mice show this is a crucial for efficient neuroinvasion.  Furthermore, 
SCID mice that lack mature FDC are also refractory to prion infection after 
exposure to BSE prions (Brown et al., 1997).  Here, high levels of PrPd consistent 
with association upon FDC were detected in almost all the spleens from the 
prion-infected young RIII mice and C57BL mice (Figure 3, Table 1).  In aged 
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mice, despite the absence of clinical and histopathological signs of disease in the 
CNS, heavy PrPd accumulations were also detected upon the few intact FDC 
remaining in the spleens of most of the BSE-challenged RIII mice (9/16) and 2/9 
of the C57BL mice (Fig. 3, Table 1).  
 210 
FDC status is adversely affected in the spleens of aged RIII mice   
We have previously shown that the status of FDC and their ability to trap and 
retain immune complexes are compromised in the spleens of aged C57BL mice 
(Brown et al., 2012, Brown et al., 2009).  We therefore determined whether aging 
also adversely affected FDC status in RIII mice.  FDC in the spleens of young 
mice express high levels of complement receptor (CR) 1 and CR2, cellular PrPC 
and trap and retain large amounts of complement component C4 on their 
surfaces (McCulloch et al., 2013, Taylor et al., 2002, Zabel et al., 2007) (Fig. 4).  
The expression of CR2/CR1 by FDC in the spleens of aged mice was similar to 
that observed in young mice (Fig. 4).  However, the majority of FDC networks in 220 
the spleens of the aged RIII mice showed reduced expression of PrPC and 
impaired retention complement component C4 (Fig. 4a), as observed in the 
spleens of aged C57BL mice (Fig. 4c) (Brown et al., 2012, Brown et al., 2009). 
Morphometric analyses confirmed that in the spleens of the aged RIII mice (Fig. 
4b) and C57BL mice (Fig. 4d) the number and size of the PrPC-expressing FDC 
networks, and the level of trapped C4 on their surfaces, were significantly 
reduced.  The expression of PrPC by FDC, and their ability to trap and retain 
complement-containing immune complexes, are each important for the efficient 
retention and replication of prions upon their surfaces (Klein et al., 2001, Mabbott 
et al., 2001, McCulloch et al., 2011, Michel et al., 2012, Zabel et al., 2007).  Our 230 
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data show that these characteristics are dramatically affected in the spleens of 
aged RIII mice (Fig. 4a & 4b) and aged C57BL mice (Fig. 4c & 4d).   
 
Aging adversely affects the distribution of MZ macrophages in the spleens 
of aged C57BL mice, but not aged RIII mice 
The splenic MZ surrounds the white pulp and comprises a distinct channel of 
mucosal vascular adressin cell-adhesion molecule 1 (MADCAM1)-expressing 
sinus lining cells through which blood percolates on its way to the red pulp.  
Specific populations of macrophages and B cells are firmly attached to this 
network, enabling the continuous surveillance and clearance pathogens, toxins 240 
and apoptotic cells from the blood-stream (Mebius & Kraal, 2005).  MZ B cells 
also capture blood-borne immune complexes and rapidly shuttle them to FDC 
(Cinamon et al., 2008).  We and others have previously reported that the MZ 
microarchitecture is disturbed in the spleens of aged C57BL mice, impeding the 
delivery of immune-complexes and prions to FDC (Birjandi et al., 2011, Brown et 
al., 2012).  We therefore determined whether similar disturbances to the MZ 
microarchitecture occurred in the spleens of aged RIII mice.  First, we graded the 
disruption to the network of MADCAM1-expressing sinus lining cells, and 
detected a significant disruption to this network in spleens from aged RIII and 
C57BL mice (Fig. 5a & 5b).  In young mice, marginal metallophilic (MM) 250 
macrophages (CD169+ cells) typically form a continuous thin rim at the inner 
border of the MZ, but in aged mice this area was likewise thickened, distorted 
and broken (Fig. 5a). Morphometric analysis confirmed that the MM macrophage 
layer was also significantly disrupted (Fig. 5c) and significantly thicker (Fig. 5d) in 
the spleens of aged RIII and C57BL mice, when compared to young mice.  
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The MZ also contains an outer ring of MZ macrophages expressing the C-type 
lectin SIGNR1.  The distribution of SIGNR1+ MZ macrophages was also 
significantly reduced in the spleens of aged C57BL mice when compared to 
young mice (Fig. 6; P < 0.0003, Mann-Whitney U-test).  However, the distribution 260 
of the SIGNR1+ MZ macrophages in the spleens of aged RIII mice was similar to 
that observed in young RIII mice (Fig. 6; P = 0.16, Mann-Whitney U-test).  
Together, these data reveal that although the distribution of the MADCAM1+ 
sinus lining cells and CD169+ MM macrophages was significantly disturbed in the 
MZ of aged RIII mice (as observed in aged C57BL mice), the distribution of 
SIGNR1+ MZ macrophages was not adversely affected in the spleens of aged 
RIII mice.   
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Discussion 270 
Here we show that the susceptibility of aged mice to prion disease after exposure 
to primary BSE is dramatically reduced.  Furthermore, there were no 
histopathological signs of prion disease in any of the brains from the BSE-
injected aged mice.  In addition, PrPSc was undetectable in all the brains from the 
BSE-injected aged C57BL mice and only detected in a small foci (the vestibular 
nucleus) of the brain of one of the aged RIII mice.  An intact immune system is 
important for cross-species transmission of BSE prions (Brown et al., 1997).  
Here, the effects of aging on prion susceptibility after BSE-exposure coincided 
with disturbances to FDC and the microarchitecture of the MZ in the spleen.  
However, despite the absence of clinical and histopathological signs of prion 280 
disease in the CNS, heavy PrPd accumulations were detected upon the 
remaining intact FDC in the spleens of many of the BSE challenged aged RIII 
mice and some of the aged C57BL mice.  The detection of PrPd in spleens of 
BSE-injected aged mice in the absence of neuropathological signs and clinical 
disease has important implications for human health and the potential for the 
horizontal spread of vCJD, for example by accidental iatrogenic transmission.   
 
Following the emergence of BSE in the 1980s it was estimated that over half a 
million infected cattle may have entered the UK food chain (Valleron et al., 2001, 
Wilesmith, 1993).  Despite the probable widespread exposure of the UK 290 
population to the BSE agent via contaminated foodstuffs (Valleron et al., 2001) 
the number of confirmed clinical cases of vCJD remains relatively low (Bishop et 
al., 2013).  Furthermore, analysis of the age ranges of the definite and probable 
clinical vCJD cases recorded in the UK reveals a striking age-related distribution 
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(Fig. S1).  Of the 177 probable and definite cases reported to-date (August 
2013), only 5 had occurred in eldery patients (2.8%; ≥60 years old), and 20 
(11%) in middle aged individuals (~45-60 years old).  Therefore, in order to study 
the effects of aging on prion pathogenesis in a laboratory mouse model, two age 
groups were used: young adult mice (six to eight weeks old), and 
immunosenescent aged (elderly) mice (~600 d old). 300 
 
The splenic MZ is a specialized microenvironment which plays an important role 
in the capture and removal of blood-borne immune complexes, pathogens and 
their toxins (Mebius & Kraal, 2005).  The continual shuttling of MZ B cells 
between the MZ and follicles is also important for the efficient delivery of blood-
borne, complement-opsonized immune complexes to FDC (Cinamon et al., 
2008).  Prion replication upon PrPC-expressing FDC is crucial for the efficient 
spread of infection to the CNS (Brown et al., 1999, Mabbott et al., 2000, 
McCulloch et al., 2013, Montrasio et al., 2000).  Data suggest that an intact MZ is 
also required to facilitate the initial delivery of complement-opsonized prions to 310 
FDC (Brown et al., 2012).  We have previously shown that the effects of aging on 
prion disease susceptibility are not simply due to reduced Prnp mRNA (which 
encodes PrPC) expression levels in the CNS, or effects on the density or 
distribution of peripheral nerves in lymphoid tissues (Brown et al., 2012, Brown et 
al., 2009).  Although aging-effects on other host factors cannot be entirely 
excluded, our data imply that the aging-related changes to FDC status and the 
MZ microarchitecture are likely to have had the major influence on prion disease 
susceptibility in the BSE-injected aged mice by impeding the initial delivery of 
prions into the B-cell follicles and reducing the availability of PrPC-expressing 
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FDC.  Similarly, the significant changes to the thickness and distribution of the 320 
CD169+ MM macrophages in the MZ may also have impeded the delivery of 
prions to FDC in aged mice by aiding their sequestration and clearance.   
 
In the aged spleens from each mouse strain there were highly significant 
reductions to the number and size of the PrPC-expressing FDC networks, but 
small numbers of intact (PrPC-expressing) FDC were evident.  In the current 
study heavy PrPd accumulations were detected upon the remaining intact FDC in 
the spleens of many of the BSE-challenged RIII mice, but in a much smaller 
proportion of spleens from aged C57BL mice.  The reasons for these apparent 
mouse strain-specific differences in splenic PrPd accumulation are uncertain.  330 
Both the RIII mice and C57BL mice share the same PrP genotype (Prnpa; (Lloyd 
et al., 2004)).  The effects of aging on the number and size of the PrPc-
expressing FDC networks were similar for each mouse strain, as was the aging-
associated disruption to the network of MADCAM1-expressing sinus lining cells 
and the distribution and thickness of the CD169+ MM macrophage layer in the 
MZ.  However, the effects of aging in the distribution of SIGNR1+ MZ 
macrophages differed between mouse strains: their distribution was significantly 
impaired in the MZ of aged C57BL mice, but appeared to be unaffected in aged 
RIII mice.  C-type lectins such as SIGNR1 recognize specific carbohydrate 
structures that are present on cell-wall components of pathogens (Lanoue et al., 340 
2004).  Since the prion protein is highly glycosylated, it is plausible that SIGNR1 
may play a similar role in the recognition and uptake of prions in the splenic MZ. 
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We have previously shown that whereas the susceptibility of aged mice to 
peripheral exposure with mouse-passaged scrapie prions was dramatically 
reduced, no effect on disease susceptibility was observed when prions were 
injected directly into the brain by intracerebral (i.c.) injection (Brown et al., 2012, 
Brown et al., 2009).  However, in the current study aged mice were refractory to 
clinical prion disease after injection with primary BSE prions by combined i.c. and 
intraperitoneal injection.  After peripheral exposure FDC are considered to 350 
amplify prions above the threshold required to achieve neuroinvasion (Mabbott, 
2012, McCulloch et al., 2011).  We have previously shown that young SCID mice 
which lack mature FDC in their spleens are also refractory to prion disease after 
i.c. injection with primary BSE prions (Brown et al., 1997).  These data imply that 
the routing of prions through an intact lymphoreticular system is import for 
efficient neuroinvasion after cross-species transmission.  These data also 
suggest that after interspecies prion exposure, the processing and replication of 
prions upon FDC in the peripheral lymphoid tissues is important for their 
adaptation to the new host and their ability to subsequently infect the nervous 
system.  Data in the current study showing that the effects of aging on FDC 360 
status and the marginal zone are coincident with reduced prion disease 
susceptibility, are consistent with the reduced availability of replication sites 
(PrPC-expressing FDC) in the spleen upon which the cattle BSE prions can adapt 
to the new host (mouse) environment, dramatically limiting their ability to 
replicate and subsequently spread to the brain.   
 
Retrospective analyses prion-specific PrPSc accumulation in archived appendix 
and tonsil samples (Clewley et al., 2009, Hilton et al., 2002, Hilton et al., 2004) 
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suggest that the prevalence of vCJD in the UK population may be much higher 
than the clinical case data alone, implying the potential existence of a subclinical 370 
carrier state (Clewley et al., 2009, Garske & Ghani, 2010).  Similarly, vCJD 
accumulation was detected in the spleen of an asymptomatic individual who was 
heterozygous (MV) at codon 129 of the prion protein gene (PRNP in humans) 
(Bishop et al., 2013, Peden et al., 2004).  These data show that significant levels 
of vCJD prions can accumulate in the lymphoid tissues of infected individuals in 
the absence of observable clinical signs.  These data suggest that the exposure 
of aged individuals to BSE may likewise have led to the accumulation of 
significant levels of vCJD prions within their lymphoid tissues in the absence of 
obvious clinical and histopathological signs of CNS involvement.  Data presented 
here are consistent with data published elsewhere which show that low dose 380 
prion exposure (Thackray et al., 2003), immunodeficiency (Frigg et al., 1999) and 
cross-species prion transmission (Hill et al., 2000), like aging, can under some 
circumstances result in subclinical prion disease in affected individuals.  
However, in contrast to the above examples we did not observe significant 
evidence of PrPSc accumulation or neuropathology in the brains of any of the 
primary BSE-injected aged mice.  Our data suggest that the effects of aging on 
FDC status and the MZ had impeded the replication of prions in the spleen, 
blocking or substantially delaying neuroinvasion.   
 
Data in the current study raise important issues for human health and the 390 
potential for horizontal transmission of vCJD.  We show that aged mice did not 
succumb to clinical prion disease during their life-spans after cross-species BSE 
exposure.  However, many BSE-injected aged mice had detectable levels of PrPd 
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in their spleens.   Thus, although the combined effects of aging and the species 
barrier effect may represent a significant barrier to susceptibility to clinical 
disease after cross-species prion transmission, our data suggest there may be 
significant levels of prion accumulation in the lymphoid tissues of aged 
individuals in the absence of CNS involvement.  The potential for the existence of 
a subclinical carrier state suggests a plausible risk for the horizontal spread of 
disease, for example after accidental iatrogenic exposure.  400 
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Materials and methods 
Mice.  C57BL/Dk and RIII mice were aged to ~600 d under specific-pathogen 
free conditions prior to use in subsequent studies.  Young mice were six to eight 
weeks old at the time of analysis or use in subsequent studies.  All experimental 
procedures were approved by the University of Edinburgh’s ethical review 410 
process and conducted according to the strict regulations of the UK Home Office 
Animals (Scientific Procedures) Act 1986.    
 
BSE agent exposure and disease monitoring.  The BSE source used in this 
study was cattle brain homogenate from the brain of a clinically-affected UK 
Friesian Holstein cow (PG63/87) collected on 1/10/1987.  This material has been 
used in a range of primary transmissions to mice at this Institute (eg: (Bruce et 
al., 1997, Fraser et al., 1992)) and produces a characteristic pattern in the mice 
consistent with classical BSE.  Groups of C57BL and RIII (both of the Prnpa 
genotype; (Lloyd et al., 2004)) were injected with a 10% (wt/vol) brain 420 
homogenate of cattle BSE by a combination of the i.c. (20 µl) and intraperitoneal 
(100 µl) routes (Brown et al., 1997, Bruce et al., 1997).  These mouse strains 
were selected as previous transmissions of BSE show they produce highly 
reproducible incubation periods of disease and distinct patterns of vacuolar 
degeneration in their brains (Bruce et al., 1997).  Following BSE exposure, mice 
were coded and assessed weekly for signs of clinical disease.   The clinical 
endpoint of disease was determined by rating the severity of clinical signs of 
prion disease exhibited by the mice. Following clinical assessment, mice were 
scored as “unaffected”, “possibly affected” and “definitely affected” using 
standard criteria which typically present in mice clinically-affected with prion 430 
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disease.  The clinical endpoint of disease was defined in one of the following 
ways: i) the day on which a mouse received a second consecutive “definite” 
rating; ii) the day on which a mouse received a third “definite” rating within four 
consecutive weeks; iii) the day on which a mouse was culled in extremis. 
 
The following criteria were used to help distinguish between the clinical signs of 
ageing (senility) in mice from those of prion disease (Brown et al., 2012).  The fur 
of aged mice fur may lose colour and appear less sleek.  Body shape may 
gradually change.  Senile mice may have a “vacant stare” whereby the face looks 
thinner and the eyes not as bright.  Mice beginning to display clinical signs of 440 
prion are often more motile and become more conspicuous, whereas those 
displaying definite positive signs are immobile and less interactive with their cage 
mates.  In contrast, senile mice still move round their cages and interact with 
their cage mates.  Survival times were recorded for mice that did not develop 
clinical signs of disease and were culled when they showed signs of intercurrent 
disease.  Prion diagnosis was confirmed by histopathological assessment of 
vacuolation in the brain.  For the construction of lesion profiles, vacuolar changes 
were scored in nine grey-matter areas of each brain as described (Bruce et al., 
1997).   
 450 
IHC.  For the detection of disease-specific PrP (PrPd) tissues were fixed 10% 
formal saline for 48 h and treated for 1h in 98% formic acid to reduce infectious 
BSE titre prior to ex-vivo analysis. Sections (thickness, 6 µm) were 
deparaffinised, and pre-treated to enhance the detection of PrPd by hydrated 
autoclaving (15 min, 121 ºC, hydration) and subsequent immersion in formic acid 
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(98%) for 5 min (McBride et al., 1992).  Sections were then immunostained with 
1B3 PrP-specific polyclonal antiserum (Farquhar et al., 1989) or the PrP-specific 
monoclonal antibody (mAb) BH1 (Cancellotti et al., 2013).  For the detection of 
astrocytes, brain sections were immunostained with anti-glial fibrillary acidic 
protein (GFAP; DAKO, Ely, UK).  For the detection of microglia, deparaffinised 460 
brain sections were first pre-treated with Target Retrieval Solution (DAKO) and 
subsequently immunostained with anti-ionized calcium-binding adaptor molecule 
1 (Iba-1; Wako Chemicals GmbH, Neuss, Germany).  Immunolabelling was 
revealed using horseradish peroxidase conjugated to the avidin-biotin complex 
(HRP: Novared kit, Vector laboratories, Peterborough, UK).  PET immunoblot 
analysis of brain was used to confirm that PrPd detected by 
immunohistochemistry was PK-resistant PrPSc.  Membranes were subsequently 
immunostained with 1B3 PrP-specific polyclonal antiserum and developed as 
described (Schulz-Schaeffer et al., 2000).   
To compare the status of FDC and the MZ microarchitecture spleens were 470 
snap-frozen in liquid nitrogen and frozen sections (thickness, 10 µm) were fixed 
in acetone.  FDC were visualised by staining with mAb FDC-M2 (212-MK-
1FDCM2; ImmunoKontact) to detect complement component C4 and mAb 7G6 
to detect CR2/CR1 (CD21/CD35; BD Pharmingen). Cellular PrPc was detected 
using 1B3 PrP-specific polyclonal antiserum.  The following rat-anti-mouse mAbs 
were used to define the MZ microarchitecture: mAb 2DD1 which recognizes the 
C-type lectin SIGNR1 expressed on MZ macrophages (eBioscience, San Diego, 
CA); mAb MOMA-1 (AbD Serotec, UK) which recognises CD169 expressed on 
MM macrophages; mAb MECA-367 which detects MAdCAM1 (AbD Serotec, UK) 
on the endothelial cells lining the MZ sinus. For immunofluorescent labelling 480 
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species-specific secondary antibodies coupled to Alexa Fluor 488 (green), Alexa 
Fluor 594 (red) or Alexa Fluor 647(blue) dyes (Invitrogen Life Technologies) were 
used.  For visualisation at light level the avidin-biotin complex technique (HRP: 
Novared kit, Vector laboratories, Peterborough, UK) was used.  
 
Semi-quantitative scoring of disturbances to MZ architecture.  Well-oriented 
white pulp areas of spleen were selected at random from sections from four mice 
from each mouse group.  MZ disruption was measured using a semi-quantitative 
scoring method (Fig. 5b-d & 6c) as described (Birjandi et al., 2011).  Briefly, 
coded spleen sections were first immunostained to detect the marker of interest 490 
(CD169, MADCAM1, SIGNR1).  The relative distortion of the splenic MZ was 
then characterized by comparing the following criteria: thickness of the cell layer; 
advancement cells of the MZ into the white pulp; presence of discontinuous ring 
of immunolabelling indicating disruption to the MZ. Grading of each image was 
scored as follows: 1, no disruption/minimal; 2, moderate; 3, severe (Fig. 5b & 5c).  
To quantify the MZ thickness, the depth of the cell layer was measured at three 
separate points from four randomly selected white pulp areas from four mice 
from each mouse group.  For the quantitation of SIGNR1 expression on MZ 
macrophages, 4 randomly selected fields of view were collected from each 
mouse from each group and the % area of SIGNR1+ immunolabeling in each 500 
field quantified using ImageJ software (http://rsbweb.nih.gov/ij/).  
 
Image analysis and quantitation of PrPc expression on FDC networks.  The 
area of PrPc expression upon FDC was quantified using ImageJ software as 
described previously (Brown et al., 2012, Brown et al., 2009, McCulloch et al., 
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2011, McCulloch et al., 2013).  From each spleen, three sections were studied 
and on each section data from three randomly selected fields of view containing 
individual FDC networks were collected. Therefore from each group data from a 
total of 36 individual FDC were analysed.   
 510 
Statistical analyses.  Data are presented as mean ± SE.  Unless otherwise 
indicated, differences between groups were statistically compared using a 
student t-test.  In instances where there was evidence of non-normality, data 
were analysed by a Mann-Whitney U-test.  Values of P < 0.05 were accepted as 
significant. 
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Fig. 1. Effect of host age on the development of neuropathology (spongiform 
vacuolation) within the brain following primary BSE infection.  (a & b) 
Histopathological analysis of brains BSE-injected young (closed circles) and 
aged (open circles) RIII (a) and C57BL mice (b).  Vacuolation was scored on a 
scale of 1 to 5 in nine gray matter areas: 1, dorsal medulla; 2, cerebellar cortex; 710 
3, superior colliculus; 4, hypothalamus; 5, thalamus; 6, hippocampus; 7, septum; 
8, retrosplenial and adjacent motor cortex; 9, cingulate and adjacent motor 
cortex. Each point represents the mean vacuolation score ± SEM for groups of 9 
to 14 mice. (c & d) Histopathological analysis of the spongiform vacuolation in the 
hypothalamus and cochlear nucleus of BSE-injected mice.  Characteristic 
spongiform pathology were detected in the brains of clinically-affected RIII mice 
(c, upper panels) and C57BL mice (d, upper panels).   However, no evidence of 
spongiform pathology was detected in any of the brains from the BSE-injected 
aged RIII mice (c, lower panels) and C57BL mice (d, lower panels).  
Representative images from the brains of control aged mice of equivalent ages 720 
are shown for comparison.  Scale bar = 10 µm. 
 
Fig. 2. Histopathological analysis of the characteristic signs of prion disease in 
the brains of the BSE-injected young and aged mice.  (a) Cartoons illustrating the 
anatomical brain regions analysed.  In young RIII mice (b) and C57BL mice (d) 
pathology consistent with terminal BSE infection was observed in the brains of all 
the clinically-affected mice. The typical neuropathological signs included heavy 
accumulations of disease specific PrP (PrPd, brown, second column), reactive 
astrocytes expressing high levels of GFAP (brown, third column) and active 
microglia expressing Iba-1 (brown, fourth column).  PET immunoblot analysis of 730 
Brown et al. Aging & BSE 
 
29 
 
adjacent sections confirmed the PrPd accumulations were PK-resistant PrPSc 
(black, first column). (c & e) In contrast, none of the aged mice had detectable 
histopathogical signs of prion disease in their brains.  The exception was one 
clinically-negative, BSE-injected aged RIII mouse which had evidence of PrPd 
accumulation only in the vestibular nucleus (see Fig. 3a). 
 
Fig. 3. Comparison of the accumulation of disease-specific PrP (PrPd) in the 
brains and spleens of BSE-injected young and aged mice.  In contrast to the 
brains of clinically-affected young mice, the brains of all but one of the BSE-
injected, clinically-negative aged RIII (a) and all of the BSE-injected, clinically-740 
negative aged C57BL mice (b) lacked evidence of PrPd accumulation (brown) in 
their brains.  However, PrPd accumulations were detected in the spleens of most 
(9/16) of the BSE challenged RIII mice (a) and 2/9 of the C57BL mice (b).  
Sections were counterstained with haematoxylin (blue).  Arrow in “a” shows PrPd 
accumulation in the vestibular nucleus.  Scale bar  = 20 µm. 
 
Fig. 4.  Effect of host age on FDC status in the spleen.  Immunofluorescent 
analysis of FDC status in aged and young RIII mice (a) and C57BL mice (c).  
FDC in the spleens of young mice typically express high levels of the 
complement receptors CR2/CR1 (red) and cellular PrPc (green) and trap 750 
complement component C4 (blue) on their surfaces of FDC (left-hand panels). In 
contrast, most of the FDC networks in the spleens of RIII mice and C57BL aged 
mice appeared to be disrupted and the expression of PrPc and retention of 
complement component C4 and was dramatically reduced (right-hand panels).  
Scale bar = 50 µm.  Morphometric analyses of the effect of host age on the size 
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of the CR2/CR1-expressing FDC networks, number and size of PrPC-expressing 
FDC, and area of trapped C4 on the surface of FDC in the spleens of RIII mice 
(b) and C57BL mice (d).  Differences between groups were analysed by a Mann-
Whitney U-test.   
 760 
Fig. 5.  Effect of host age on the microarchitecture of the splenic MZ.  (a) IHC 
analysis of the distribution of MADCAM1-expressing sinus lining cells (upper row, 
brown) and CD169-expressing MM macrophages (lower row, brown)  in the MZ 
of young and aged RIII and C57BL mice.  MZ, marginal zone; RP, red pulp; WP, 
white pulp; FO, FDC-containing B-cell follicle.  Scale bar = 20 µm.  (b) Semi-
quantitative assessment of the effects of aging on the distribution to the layers of 
MADCAM1+ sinus lining cells (b) and CD169+ MM macrophages (c) in the 
spleen.  Immunostained spleen sections were coded and four fields of 
view/mouse scored on a scale of 1 normal, to 3 severely disrupted.  
Representative images for each grade are shown.  Differences between groups 770 
were analysed by a Student’s t-test.  (d) The effects of aging on the thickness of 
the layer of CD169+ MM macrophages.  Coded spleen sections from each mouse 
group were immunostained to detect CD169 (green) and the thickness of the cell 
layer measured at three distinct sites in four fields fields of view/mouse.  
Differences between groups were analysed by a Mann-Whitney U-test.   
 
Fig. 6.  Effect of host age on the distribution of C-type lectin SIGNR1-expressing 
MZ macrophages. (a & b) Comparison of SIGNR1 expression on MZ 
macrophages (red) and CD169 expression on MM macrophages (green) in the 
spleens of RIII mice (a) and C57BL mice (b).  Typically, CD169+ MM 780 
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macrophages are situated within an inner ring in the MZ whereas the SIGNR1+ 
MZ macrophages are positioned within the outer border of the MZ.  (a) In the 
spleens of aged RIII mice whereas the layer of CD169 MM macrophages was 
dramatically disrupted, the level of distribution of SIGNR1+ MZ macrophages 
appeared similar to that observed in young mice.  (b) In the spleens of aged 
C57BL mice the distribution of the CD169+ MM macrophages and SIGNR1+ MZ 
macrophages each appeared to be adversely affected when compared to young 
mice.  MZ, marginal zone; RP, red pulp; WP, white pulp.  Scale bar = 50 µm.  (c) 
Morphometric analysis of the mean area of SIGNR1+ pixels/image in spleens 
from each mouse group.  Differences between groups were analysed by a Mann-790 
Whitney U-test.   
 
Supplementary Fig. 1.  Number of variant Creutzfeldt-Jakob (vCJD) cases in 
the UK by 10 year age group.  Data show the total number of definite (confirmed) 
and probable (without neuropathological confirmation) vCJD cases for each 
patient group up to August 2013.  One probable/definite vCJD patient was alive 
at the time of analysis.  These data were kindly supplied by Prof. James Ironside 
(National CJD Research & Surveillance Unit, University of Edinburgh, UK). 






